A Study of MK0359 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0359-016)

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00482235

Enrollment

Registered

2007-06-05

Start date

2002-12-31

Completion date

2003-04-30

Last updated

2015-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Brief summary

A study to test the effect of MK0359 in lessening the symptoms of COPD as compared to salmeterol and placebo.

Interventions

DRUGMK0359

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE

Eligibility

Sex/Gender

ALL

Age

40 Years to 75 Years

Healthy volunteers

Inclusion criteria

* You are between the ages of 40 and 75 * You have had a history for at least a year of COPD symptoms * You have a history of smoking one pack of cigarettes per day for 10 years

Exclusion criteria

* You have been in a research study with an investigational drug or vaccine in the last 4 weeks. * You have donated blood in the last 4 weeks. * You have been hospitalized or had major surgery in the last 4 weeks * You have been treated in the emergency room within the last 2 months or hospitalized within the last 3 months for your COPD symptoms * You have a history of heart problems in the last 6 months * You have a history of stomach problems * You are unwilling to avoid grapefruit juice throughout the study

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026